Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome

N.M. van Sorge, W.L. van der Pol, M.D. Jansen, L.H. van den Berg

Research output: Contribution to journalReview articlepeer-review

Abstract

Guillain-Barré syndrome (GBS) is a postinfectious inflammatory polyradiculo-neuropathy characterized by flaccid paralysis. Antibodies directed against glycolipid structures (gangliosides), which are highly expressed in the peripheral nervous system, are frequently detected in sera from GBS patients. These antibodies interfere with nerve conduction and have been shown to activate phagocytes via IgG receptors (FcgammaR). These findings support an important role of glycolipid-specific antibodies in the pathogenesis of GBS.

Original languageEnglish
Pages (from-to)61-68
Number of pages8
JournalAutoimmunity Reviews
Volume3
Issue number2
DOIs
Publication statusPublished - Feb 2004

Keywords

  • Antibodies
  • Gangliosides
  • Guillain-Barre Syndrome
  • Humans
  • Inflammation
  • Receptors, Fc
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review

Fingerprint

Dive into the research topics of 'Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome'. Together they form a unique fingerprint.

Cite this